In conclusion, despite these limitations, our meta-analysis advocates that methylated SOX17, CDO1, ZFP42, TAC1, FAM19A4, FHIT, MGMT, p16, and RASSF1A are useful biomarkers in the screening and auxiliary detection of lung cancer. This evidence concerns the gene CDO1 and lung carcinoma.